Ayala Pharmaceuticals Inc (ADXS)

[fbg0316]

Agree James. Also, the source of the post of the so called conversation with the company has historically been loose with facts and made subjective assertions without much basis (i.e., my friend at the big firm said such and such...). And remember not long ago, he was saying he thought ADXS could sell AXAL for $1 billion as I recall, whereas now he has changed his tune to saying he thought all along the AXAL cervical trial was too costly and would take too long and should be scrapped.